← Leaderboards
Patrick T Murray
University Of Chicago
$621,405
Attributed
$621,405
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$621,405 · 2
By mechanism
K23$621,405 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Richard J Quigg$9,965,129
- Patrick N Cunningham$2,297,642
- Jay L Koyner$2,844,723
- Nuala Jennings Meyer$12,062,038
- Jerrold S. Levine$1,835,208
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationKidney CirculationHuman Therapy EvaluationHuman SubjectHemodynamicsFenoldopamAcute Renal FailureVasopressinsClinical TrialsPhenylephrinePlacebosSeptic ShockVasoconstrictorsCombination ChemotherapyChemopreventionCatecholaminesKidney Disorder ChemotherapyKidney FunctionMethod DevelopmentNorepinephrinePatient Care ManagementPatient Oriented ResearchPerfusionClinical Research
Grant awards (8)
Effects of Vasoactive Drugs on Perfusion in Septic Shock$124,281
K23 · FY2005 · GM
Effects of Vasoactive Drugs on Perfusion in Septic Shock$124,281
K23 · FY2004 · GM
Effects of Vasoactive Drugs on Perfusion in Septic Shock$124,281
K23 · FY2003 · GM
Effects of Vasoactive Drugs on Perfusion in Septic Shock$124,281
K23 · FY2002 · GM
FENOLDOPAM IN RENAL AND SYSTEMIC PERFUSION IN CRITICALLY ILL PTS W SIRS$0
M01 · FY2002 · RR
Effects of Vasoactive Drugs on Perfusion in Septic Shock$124,281
K23 · FY2001 · GM
FENOLDOPAM IN RENAL AND SYSTEMIC PERFUSION IN CRITICALLY ILL PTS W SIRS$0
M01 · FY2000 · RR
FENOLDOPAM IN RENAL AND SYSTEMIC PERFUSION IN CRITICALLY ILL PTS W SIRS$0
M01 · FY2000 · RR